AABB, America’s Blood Centers and the American Red Cross, which collectively represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals, are submitting these comments on the interim final rule with comment period, CMS3401-IFC: Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments of 1988 (CLIA), and Patient Protection and Affordable Care Act; Additional…
Read MoreThe following statement has been issued by AABB, America’s Blood Centers and the American Red Cross regarding the status of the nation’s blood supply: The blood supply in the United States is critically low and the majority of the country’s blood centers are reporting significant declines in their blood collections. As the nation confronts new…
Read MoreOn September 23, 2020, Kate Fry, CEO at America’s Blood Centers, provided testimony before the U.S. International Trade Commission on the role of independent blood centers during the COVID-19 pandemic. Key highlights include the critical role and experience of community blood centers during the COVID-19 pandemic, including the collection of COVID-19 Convalescent Plasma, shifting operations to maintain…
Read MoreAABB, America’s Blood Centers, and the American Red Cross request that the Committee on Equitable Allocation of Vaccine for the Novel Coronavirus prioritize blood centers by recognizing them as health care facilities for the purpose of the vaccine allocation framework and at a minimum, classifying workers at these establishments as critical risk workers. Collectively, our…
Read MoreOn September 4, 2020, AABB, America’s Blood Centers, and the American Red Cross jointly submitted comments addressing the need to identify blood centers as health care facilities for the purpose of vaccine allocation.
Read MoreAmerica’s Blood Centers (ABC) submitted joint comments to the docket on June 5, 2020 with AABB, American Red Cross (ARC), and the Plasma Protein Therapeutics Association (PPTA) on “Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products”, April 2020. Again, we appreciate the FDA’s efforts to support the…
Read MoreAmerica’s Blood Centers is the national trade association for independent, community blood centers who collect 60 percent of the nation’s blood supply and more than 80 percent of COVID-19 Convalescent Plasma (CCP). We and our member blood centers continue to support and prioritize both the safe collection and equitable distribution of CCP. We support the…
Read MoreJuly 30, 2020 America’s Blood Centers is the national trade association for independent community blood centers. Our members are responsible for close to 60 percent of the nation’s blood supply and have been at the forefront of convalescent plasma collections in the U.S. over the past four months. To date, independent community blood centers (non-American…
Read MoreAmerica’s Blood Centers (ABC) is providing feedback to the Solicitation for Public Comments on Section 209 of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act. ABC thanks HHS for soliciting public comments on this important report and for providing the additional time needed to assemble invaluable lessons learned during the beginning of this current…
Read More
Joint Letter to FDA on EUA Extension
AABB, America’s Blood Centers and the American Red Cross, which collectively represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals, have jointly submitted a letter to FDA to request an extension on the deadline to implement the new CCP EUA requirements.
Read More